What is Prime Medicine's cumulative cost basis?

Prime Medicine (PRME) reported cumulative cost basis of $71.39M in Q1 2026.

How has Prime Medicine's cumulative cost basis changed year-over-year?

Prime Medicine's cumulative cost basis increased by 47.3% year-over-year, from $48.48M to $71.39M.

What is the long-term trend for Prime Medicine's cumulative cost basis?

Over 4 years (2021 to 2025), Prime Medicine's cumulative cost basis has grown at a 113.8% compound annual growth rate (CAGR), from $5.49M to $114.57M.

Prime Medicine PRME Cumulative Cost Basis

Cumulative Cost Basis at other companies

Vertex PharmaceuticalsVRTX

——

PrecigenPGEN

——

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's cumulative cost basis?: Prime Medicine (PRME) reported cumulative cost basis of $71.39M in Q1 2026.
How has Prime Medicine's cumulative cost basis changed year-over-year?: Prime Medicine's cumulative cost basis increased by 47.3% year-over-year, from $48.48M to $71.39M.
What is the long-term trend for Prime Medicine's cumulative cost basis?: Over 4 years (2021 to 2025), Prime Medicine's cumulative cost basis has grown at a 113.8% compound annual growth rate (CAGR), from $5.49M to $114.57M.